Cargando…

Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction

PURPOSE: So far, ST-segment elevation myocardial infarction (STEMI) is still the main cause of morbidity and mortality of cardiovascular diseases worldwide. Recent studies showed that pentraxin-3 (PTX3) was related to the early diagnosis and prognosis of coronary heart disease. This study aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Sheng-Yu, Liu, Lei, Wang, Ding-Kun, Ding, Xiao-Song, Li, Wei-Ping, Li, Hong-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040170/ https://www.ncbi.nlm.nih.gov/pubmed/36987516 http://dx.doi.org/10.2147/JIR.S393703

Ejemplares similares

Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction
por: Befekadu, Rahel, et al.
Publicado: (2022)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Gao, Side, et al.
Publicado: (2019)

Predictive value of the combination of age, creatinine, and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Gao, Side, et al.
Publicado: (2020)

The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients
por: Shim, Byung-Ju, et al.
Publicado: (2010)

Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention
por: Wu, Han, et al.
Publicado: (2020)

Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention
por: Zhao, Xiaoxiao, et al.
Publicado: (2020)

Role of ST‐Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction
por: Wu, Chao, et al.
Publicado: (2023)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
por: Helseth, Ragnhild, et al.
Publicado: (2014)

Prognostic value of admission electrocardiographic findings in non‐ST‐segment elevation myocardial infarction
por: Chen, Peng‐fei, et al.
Publicado: (2020)

Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention
por: Yu, Xiao-Lin, et al.
Publicado: (2022)

Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: SÖĞÜT, Özgür, et al.
Publicado: (2021)

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Population Density Analysis of Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Japan
por: Yamaji, Kyohei, et al.
Publicado: (2020)

Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
por: Ying, Chen, et al.
Publicado: (2023)

Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: Kinetic profile, relationship to interleukin 6 and infarct size
por: Butt, Noreen, et al.
Publicado: (2020)

Prognostic value of the combination of GRACE risk score and mean platelet volume to lymphocyte count ratio in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention
por: Chen, Xinsen, et al.
Publicado: (2020)

Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Li, Yan, et al.
Publicado: (2020)

Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention: Influencing Factors and Intervention Strategies
por: Tang, Nan, et al.
Publicado: (2023)

Utilization of an Optimized Radiation Strategy in Primary Percutaneous Coronary Intervention for Patients with ST-Segment-Elevation Myocardial Infarction
por: Zhong, Xin, et al.
Publicado: (2019)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study
por: Wang, Ying, et al.
Publicado: (2021)

The predictive value of relative wall thickness on the prognosis of the patients with ST-segment elevation myocardial infarction
por: Zhang, Ying, et al.
Publicado: (2023)

Prognostic value of rising mean platelet volume during hospitalization in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
por: Avci, Eyup, et al.
Publicado: (2018)

The prognostic value of left atrial and left ventricular strain in patients after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
por: Chu, Ai-Ai, et al.
Publicado: (2020)

The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga L., et al.
Publicado: (2013)

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction
por: Li, Jing-Wei, et al.
Publicado: (2017)

Prognostic nutritional index predicts clinical outcome in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Chen, Qing-Jie, et al.
Publicado: (2017)

Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Konishi, Takao, et al.
Publicado: (2017)

Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction
por: Chen, Yan, et al.
Publicado: (2022)

Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A propensity score-matched retrospective study
por: Xue, Yu-Long, et al.
Publicado: (2021)

Stent Thrombosis after Rescue Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction
por: Thani, Khalid Bin, et al.
Publicado: (2015)

Smoker's Paradox in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Tanush, et al.
Publicado: (2016)

Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST‐Segment–Elevation Myocardial Infarction
por: Sulaiman, Samian, et al.
Publicado: (2021)

Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2021)

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
por: Qian, Geng, et al.
Publicado: (2022)

Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Chen, Xinsen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8n90r99qo9v2r3f7v010ufa9tf